Form 4: Clorox Director Esther Lee Reports Acquisition of Deferred Stock Units

Director Esther Lee reports the acquisition of deferred stock units in Clorox through dividend reinvestment and an annual award, increasing her holdings.

Summary

• Director Esther Lee filed a Form 4 detailing changes in her beneficial ownership of Clorox stock.
• She acquired deferred stock units through dividend reinvestments on February 9, 2024 (94.8829 units), May 10, 2024 (102.1969 units), August 30, 2024 (94.8694 units), and November 7, 2024 (92.981 units).
• Lee also received an annual award of 1,000.7162 deferred stock units on December 31, 2024.
• These transactions increased her total holdings to 13,499.0331 deferred stock units.
• The deferred stock units will be settled in Clorox stock upon her retirement or termination of service as a Director.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock unit acquisitions by a director, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Positives

• The director's increased stake in the company could be interpreted as a sign of confidence in Clorox's future performance.
• The acquisition of shares through dividend reinvestment shows a long-term commitment to the company.

Future Outlook

The director's deferred stock units will be settled in Clorox stock upon retirement or termination of service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Comparison to Industry Standards

• Comparing Esther Lee's compensation structure to other directors in similar consumer staples companies like Procter & Gamble (PG) or Colgate-Palmolive (CL) would provide context on whether the deferred stock unit awards are standard practice.
• Reviewing the proxy statements of these companies would reveal the typical compensation packages for board members, including the mix of cash, stock options, and deferred stock units.
• Benchmarking the vesting schedules and settlement terms of the deferred stock units against industry norms would also be beneficial.

Stakeholder Impact

• The increased holdings of a director may signal confidence to shareholders.
• The compensation structure impacts the company's financials and is of interest to shareholders.

Key Dates